Deerfield Management Company, L.P. (Series C) Organon & Co. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Organon & Co. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 16,388 shares of OGN stock, worth $147,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,388Holding current value
$147,819% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OGN
# of Institutions
794Shares Held
210MCall Options Held
2.74MPut Options Held
1.79M-
Black Rock Inc. New York, NY32.6MShares$294 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$291 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.2MShares$92.3 Million0.03% of portfolio
-
State Street Corp Boston, MA9.52MShares$85.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.09MShares$82 Million0.05% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $2.29B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...